Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies.

[1]  W. Aekplakorn,et al.  Prevalence of chronic kidney disease in Thai adults: a national health survey , 2009, BMC nephrology.

[2]  W. Prasithsirikul,et al.  The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  I. Knezevic,et al.  WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[4]  D. Fife,et al.  Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia. , 2008, Pharmacogenomics.

[5]  C. Combe,et al.  Biosimilar Epoetins: An Analysis Based on Recently Implemented European Medicines Evaluation Agency Guidelines on Comparability of Biopharmaceutical Proteins , 2005, Pharmacotherapy.

[6]  S. Eiam‐Ong,et al.  Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  M. Kelley,et al.  The detection of anti-erythropoietin antibodies in human serum and plasma: part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies. , 2003, Journal of immunological methods.

[8]  H. Schellekens,et al.  When biotech proteins go off-patent. , 2004, Trends in biotechnology.

[9]  M. Daha,et al.  The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. , 2003, Journal of immunological methods.

[10]  J. Hornberger,et al.  Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Patrick Mayeux,et al.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. , 2002, The New England journal of medicine.

[12]  S S Prabhakar,et al.  Antibodies to recombinant human erythropoietin causing pure red cell aplasia. , 1997, Clinical nephrology.

[13]  R. Peces,et al.  Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. , 1996, The New England journal of medicine.